Yuriy Gusev

4.5k total citations · 1 hit paper
59 papers, 3.1k citations indexed

About

Yuriy Gusev is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yuriy Gusev has authored 59 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 33 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Yuriy Gusev's work include Cancer Genomics and Diagnostics (14 papers), MicroRNA in disease regulation (12 papers) and Cancer-related molecular mechanisms research (12 papers). Yuriy Gusev is often cited by papers focused on Cancer Genomics and Diagnostics (14 papers), MicroRNA in disease regulation (12 papers) and Cancer-related molecular mechanisms research (12 papers). Yuriy Gusev collaborates with scholars based in United States, Brazil and Romania. Yuriy Gusev's co-authors include Thomas D. Schmittgen, Daniel J. Brackett, Jinmai Jiang, Gerard J. Nuovo, Megan R. Lerner, Russell G. Postier, Subha Madhavan, Wendy L. Frankel, Daniel L. Morgan and Eun Joo Lee and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Yuriy Gusev

56 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression profiling identifies microRNA signature in pancreatic cancer

2006 740 citations Eun Joo Lee, Yuriy Gusev et al. International Journal of Cancer profile →

Peers

Countries citing papers authored by Yuriy Gusev

Since Specialization

Citations

This map shows the geographic impact of Yuriy Gusev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuriy Gusev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuriy Gusev more than expected).

Fields of papers citing papers by Yuriy Gusev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuriy Gusev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuriy Gusev. The network helps show where Yuriy Gusev may publish in the future.

Co-authorship network of co-authors of Yuriy Gusev

This figure shows the co-authorship network connecting the top 25 collaborators of Yuriy Gusev. A scholar is included among the top collaborators of Yuriy Gusev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuriy Gusev. Yuriy Gusev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Suppressor T helper type 17 cell responses in intestinal transplant recipients with allograft rejection 2024 ·Human Immunology ·(unknown), Ji‐Man Kang, Mohammed Sadat, (unknown), (unknown), (unknown), Karim Khan, Stuart S. Kaufman, Sukanya Subramanian, Yuriy Gusev, Krithika Bhuvaneshwar, Habtom W. Ressom, Rency S. Varghese, Udeme D. Ekong, Cal Matsumoto, Simon C. Robson, Thomas Fishbein, Alexander Kroemer	0
2	A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease 2022 ·GeroScience ·Fabìo Macciardi, Maria Giulia Bacalini, Ricardo Miramontes, Alessio Boattini, Cristian Taccioli, (unknown), (unknown), Laura Anderlucci, Yuriy Gusev, Thomas Groß, Robert Padilla, Massimo S. Fiandaca, Elizabeth Head, Guia Guffanti, Howard J. Federoff, Mark Mapstone	25
3	StarGazer: A Hybrid Intelligence Platform for Drug Target Prioritization and Digital Drug Repositioning Using Streamlit 2022 ·Frontiers in Genetics ·(unknown), (unknown), (unknown), Vancheswaran Gopalakrishnan, Richard N. Hanna, Eliseo Papa, (unknown), (unknown), (unknown), (unknown), (unknown), Keith Tan, Bret R. Sellman, Taylor S. Cohen, Jonathan Mangion, Faisal M. Khan, Yuriy Gusev, Khader Shameer	9
4	Variant of the Internal Model of Underwriting Risk for the Application of the Solvency II Directive 2017 ·Academy of Accounting and Financial Studies journal ·(unknown), (unknown), Yuriy Gusev	0
5	Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors 2017 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Ewa Krawczyk, Justine N. McCutcheon, Aline Simoneti Fonseca, Bhaskar Kallakury, Paula R. Pohlmann, Yuriy Gusev, Luciane R. Cavalli	24
6	Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance 2016 ·Cancer Research ·(unknown), Linlin Luo, (unknown), Noriko Steiner, Yuriy Gusev, Bhaskar Kallakury, Eric Glasgow, Karen Creswell, Subha Madhavan, Rakesh Kumar, Geeta Upadhyay	79
7	MicroRNA analysis of breast ductal fluid in breast cancer patients 2016 ·International Journal of Oncology ·Luísa Matos do Canto, Cătălin Marian, Shawna C. Willey, Mary Sidawy, (unknown), Janice D. Rone, Xin Li, Yuriy Gusev, Bassem R. Haddad	20
8	G-DOC Plus – an integrative bioinformatics platform for precision medicine 2016 ·BMC Bioinformatics ·Krithika Bhuvaneshwar, Anas Belouali, (unknown), Robert M. Johnson, Lei Song, (unknown), Michael A. Harris, Robert Clarke, Louis M. Weiner, Yuriy Gusev, Subha Madhavan	33
9	ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer 2015 ·Journal of Experimental & Clinical Cancer Research ·Subha Madhavan, Yuriy Gusev, Salendra Singh, Rebecca B. Riggins	36
10	Preclinical Magnetic Resonance Imaging and Systems Biology in Cancer Research 2012 ·American Journal Of Pathology ·Chris Albanese, Olga Rodriguez, John W. VanMeter, Stanley T. Fricke, Brian R. Rood, Yi‐Chien Lee, (unknown), Subha Madhavan, Yuriy Gusev, Emanuel F. Petricoin, Yue Wang	19
11	miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor 2011 ·Biochemical and Biophysical Research Communications ·Jong Kook Park, Jon C. Henry, Jinmai Jiang, Christine Esau, Yuriy Gusev, Megan R. Lerner, Russell G. Postier, Daniel J. Brackett, Thomas D. Schmittgen	147
12	G-DOC: A Systems Medicine Platform for Personalized Oncology 2011 ·Neoplasia ·Subha Madhavan, Yuriy Gusev, Michael A. Harris, David M. Tanenbaum, (unknown), Krithika Bhuvaneshwar, (unknown), Kevin M. Rosso, (unknown), Lei Song, Rebecca B. Riggins, Sivanesan Dakshanamurthy, Yue Wang, Stephen W. Byers, Robert Clarke, Louis M. Weiner	45
13	MicroRNAs Are Mediators of Androgen Action in Prostate and Muscle 2010 ·PLoS ONE ·Ramesh Narayanan, Jinmai Jiang, Yuriy Gusev, Amanda Jones, Jeffrey D. Kearbey, Duane D. Miller, Thomas D. Schmittgen, James T. Dalton	49
14	Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival 2008 ·Clinical Cancer Research ·Jinmai Jiang, Yuriy Gusev, Ileana Aderca, Teresa A. Mettler, David M. Nagorney, Daniel J. Brackett, Lewis R. Roberts, Thomas D. Schmittgen	422
15	Proceedings of the 2008 MidSouth Computational Biology and Bioinformatics Society (MCBIOS) Conference 2008 ·BMC Bioinformatics ·Jonathan D. Wren, Dawn Wilkins, James C. Fuscoe, Susan M. Bridges, Stephen Winters‐Hilt, Yuriy Gusev	2
16	Computational analysis of biological functions and pathways collectively targeted by co-expressed microRNAs in cancer 2007 ·BMC Bioinformatics ·Yuriy Gusev, Thomas D. Schmittgen, Megan R. Lerner, Russell G. Postier, Daniel J. Brackett	60
17	Proceedings of the Fourth Annual Conference of the MidSouth Computational Biology and Bioinformatics Society 2007 ·BMC Bioinformatics ·Dawn Wilkins, Yuriy Gusev, (unknown), Susan M. Bridges, Stephen Winters‐Hilt, Jonathan D. Wren	2
18	Expression profiling identifies microRNA signature in pancreatic cancer breakdown → 2006 ·International Journal of Cancer ·Eun Joo Lee, Yuriy Gusev, Jinmai Jiang, Gerard J. Nuovo, Megan R. Lerner, Wendy L. Frankel, Daniel L. Morgan, Russell G. Postier, Daniel J. Brackett, Thomas D. Schmittgen	740
19	Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer 1998 ·Annals of Surgical Oncology ·Julie Ann Sosa, Marie Diener‐West, Yuriy Gusev, Michael A. Choti, Julie R. Lange, William C. Dooley, Martha A. Zeiger	95
20	Persistence of cell cycle times over many generations as determined by heritability of colony sizes of ras oncogene‐transformed and non‐transformed cells 1993 ·Cell Proliferation ·David Axelrod, Yuriy Gusev, Thomas Kuczek	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact